KYTX (Kyverna Therapeutics) Pre-Tax Income : $-91.63 Mil (TTM As of Jun. 2024)

Kyverna Therapeutics Pre-Tax Income Chart

Kyverna Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Pre-Tax Income	Get a 7-Day Free Trial				-13.09	-15.47	-20.67	-26.69	-28.80

Competitive Comparison of Kyverna Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Kyverna Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kyverna Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kyverna Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Kyverna Therapeutics's Pre-Tax Income falls into.

Kyverna Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Kyverna Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Kyverna Therapeutics's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-91.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyverna Therapeutics  (NAS:KYTX) Pre-Tax Income Explanation

Kyverna Therapeutics's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

During the past 3 years, Kyverna Therapeutics's highest Pretax Margin was -411.29%. The lowest was -465.88%. And the median was -438.59%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyverna Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Kyverna Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyverna Therapeutics Business Description